2020 AABB Annual Meeting On-Demand: Cellular Therapy Sessions


Interested in all things Cellular Therapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting.

The package includes 17 sessions (1 in Spanish) which provide you the opportunity to earn up to 16 general credits; 15 continuing medical education credits for physicians; or, 16 California Lab Personnel, Florida Lab Personnel or California Nurse contact hours.

Purchase of this package includes the on-demand recording and a downloadable MP3 audio file for each session. Presentation handouts are not available/included.

If purchasing these sessions separately it would cost $320/$400 (member/nonmember).

Access is available through December 31, 2022 so purchase this package today.

Members: $199.00
Standard: $249.00

Products

AM20-41: Engineered Microphysiological Systems -- AABB/TERMIS Joint Session

Preview Available

AM20-41: Engineered Microphysiological Systems -- AABB/TERMIS Joint Session

Oct 5, 2020 2:30pm ‐ Oct 5, 2020 3:30pm
Expiration Date: Dec 31, 2022

Presented in collaboration with Be The Match BioTherapies® 

Microphysiological systems, also often referred to as “organ-on-a-chip," are two- or three-dimensional constructs using human cells designed to model the spatial, chemical, structural, and physiological elements of in vivo cellular environments. This is currently one of the hottest research areas in the development of translational applications. Faculty in this session will explore various applications including drug screening and toxicology, tumor models for cancer diagnosis, and models for human development and diseases.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-44: Delivering Next Generation Cell and Gene Therapies: Toward FDA Approval for Early Stage Clinical Trials

Preview Available

AM20-44: Delivering Next Generation Cell and Gene Therapies: Toward FDA Approval for Early Stage Clinical Trials

Oct 5, 2020 3:45pm ‐ Oct 5, 2020 4:45pm
Expiration Date: Dec 31, 2022

Presented in collaboration with Be The Match BioTherapies®

This session will provide an overview of cell and gene therapy product development from proof-of-concept to an FDA (Food and Drug Administration)- approved clinical therapy. Speakers will address technology transfer from the academic or industry research lab to the clinical manufacturing facility. Key strategic contracts and agreements will be described. Steps required for translation to a clinical grade product including scale-up or scale-out, closed manufacturing processes, transition to clinical grade reagents and supplies and assay development will be discussed. Finally, refining the manufacturing process for IND (Investigational New Drug) submission including validation, lot release testing and stability studies will be demonstrated. Examples will include contemporary cell and gene therapy products currently progressing through clinical trials. The speakers are Principal Investigators from three of the five cell processing facilities contracted by The Production Assistance for Cellular Therapies (PACT) Program - a National Heart, Lung, and Blood Institute (NHLBI) funded resource initiative created to provide support for cell therapy-based IND-enabling translational research.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-46: Preparing Your Transfusion Service and Cellular Therapy Laboratory for Clinical Trials

Preview Available

AM20-46: Preparing Your Transfusion Service and Cellular Therapy Laboratory for Clinical Trials

Oct 5, 2020 6:00pm ‐ Oct 5, 2020 7:00pm
Expiration Date: Dec 31, 2022

Presented in collaboration with Be The Match BioTherapies®

Transfusion medicine, including blood bank, apheresis and the cellular therapy laboratory, is an integral part of a multitude and ever-growing number of clinical trials and investigations for medical innovation. Given the rapid evolution of therapies and interventions for which transfusion medicine services are required, it has become imperative that transfusion medicine professionals be well versed in the clinical trials process.

During pre-clinical and clinical development of new therapies, safety and clinical efficacy are studied. Understanding the general process of clinical trials as they progress through preparation and development, execution, and closing will help empower transfusion medicine professionals to actively participate in the process. Transfusion medicine services may be inundated with clinical trials for new therapies sponsored by industry so familiarity with different approaches to handling these trials from a transfusion medicine perspective is critical. In addition, innovation in transfusion medicine and development of clinical trials that are investigator- initiated is an integral part for the advancement of any field. Knowing how to start a clinical trial is important for academic investigators to advance their careers.

This session is designed to highlight important aspects of clinical trials development and participation that are relevant to the transfusion medicine community, with examples from blood bank, apheresis and cellular therapy laboratories.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-66: Ask the FDA

Preview Available

AM20-66: Ask the FDA

Oct 5, 2020 9:00pm ‐ Oct 5, 2020 9:00pm
Expiration Date: Dec 31, 2022

This annual event provides an opportunity for FDA and CMS/CLIA representatives to respond to member questions and present the agency's current thinking on policies, regulations, guidance documents and inspection programs that are relevant to the oversight of blood and HCT/P programs. Questions for the session are submitted in advance to regulatory@aabb.org. Identify the regulation or recommendation of interest, the specific issue or concern, and any background information, suggestions or proposed solutions to best illustrate your perspective.

Speaker(s):
Standard: Free
Members: $0.00

AM20-67: Ask the Standards

Preview Available

AM20-67: Ask the Standards

Oct 5, 2020 9:00pm ‐ Oct 5, 2020 9:00pm
Expiration Date: Dec 31, 2022

Presentations will be given by standards committee chairs who have new or revised editions to discuss. 

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-85: Innovative Cord Blood Derived Therapies

Preview Available

AM20-85: Innovative Cord Blood Derived Therapies

Oct 5, 2020 9:00pm ‐ Oct 5, 2020 9:00pm
Expiration Date: Dec 31, 2022

As the field and uses of cellular therapies grows, cord blood plays a major role. Cord blood is an amazing source material for innovative products. In this session we will explore some examples, such as NK cells for the treatment of cancer, mesenchymal stem cells for autism, and cell expansion.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-77: Desafíos Técnicos y Clínicos En El Banco De Sangre De Cordón Umbilical

Preview Available

AM20-77: Desafíos Técnicos y Clínicos En El Banco De Sangre De Cordón Umbilical

Oct 5, 2020 9:00pm ‐ Oct 5, 2020 9:00pm
Expiration Date: Dec 31, 2022

In this educational session we will delve into the unifying theme of Cord Blood Banking, an important provider of hematopoietic stem cells in Latin American countries. We will discuss the clinical, regulatory, and technical laboratory challenges they face. Emphasis will be placed on the application of the acquired knowledge by existing and emerging organizations in Spanish speaking regions of the world. This session will be imparted by experts in the field of immunogenetics, quality control, and cellular therapy, and it will be conducted entirely in the Spanish language.

Presenters will discuss the current operation status of cord blood Banks in the United States and in Latin America, the clinical utilization of this product, and the knowledge gained from recent and ongoing clinical trials. Critical regulatory elements and strategies to obtain accreditation as an international organization will be reviewed. The session will conclude with a description of different laboratory methods to identify HLA antibodies, the design of HLA antibody testing algorithms, and the elaboration of an individualized result report.

The content of this educational session was proposed by the AABB Cellular Therapy Spanish Language Subsection (SLS), based on suggestions submitted by its members and by the Spanish-speaking audience during the 2019 Annual Meeting. It will be conducted entirely in the Spanish language.

Speaker(s):
Standard: $25.00
Members: $20.00
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content